Advances in genomic testing
- 1 April 2017
- journal article
- research article
- Vol. 46 (4) , 200-204
Abstract
Background Advances in genomic technology and our understanding of Mendelian disease-causing genes have led to an increased use of genomic testing in clinical practice. Objective The aim of this paper is to outline recent advances in genetic and genomic testing and the implications for clinical practice. Discussion Next-generation genomic sequencing is improving the diagnostic yield for patients with suspected genetic disease. A molecular diagnosis for a patient with genetic disease can provide information regarding a patient's prognosis, management and reproductive risk, and identify molecular targets for treatment. However, genomic testing frequently identifies variants of uncertain significance. This is illustrated by two case examples.Keywords
This publication has 13 references indexed in Scilit:
- A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersGenetics in Medicine, 2016
- The impact of personal genomics on risk perceptions and medical decision-makingNature Biotechnology, 2016
- Towards precision medicineNature Reviews Genetics, 2016
- Genome sequencing identifies major causes of severe intellectual disabilityNature, 2014
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- Practices and Policies of Clinical Exome Sequencing Providers: Analysis and ImplicationsAmerican Journal of Medical Genetics Part A, 2013
- Disease gene identification strategies for exome sequencingEuropean Journal of Human Genetics, 2012
- Targeted capture and massively parallel sequencing of 12 human exomesNature, 2009
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Finishing the euchromatic sequence of the human genomeNature, 2004